间充质干细胞来源凋亡囊泡对感染导致急性肺损伤的治疗作用

Therapeutic effect of mesenchymal stem cell-derived apoptotic vesicles on acute lung injury induced by infection

  • 摘要:
    目的 探究人脐带间充质干细胞(hUCMSCs)来源的凋亡囊泡(ApoVs)对脂多糖(LPS)诱导的小鼠肺泡巨噬细胞(MH-S)损伤及急性肺损伤(ALI)的治疗作用。
    方法 细胞实验中,采用100 ng/ml LPS诱导MH-S细胞损伤,并给予不同浓度ApoVs(104~108 particles/ml)处理24 h,实时荧光定量逆转录聚合酶链反应(RT-qPCR)检测炎症因子白细胞介素(IL)-1β、IL-6、肿瘤坏死因子-α(TNF-α)表达;动物实验中,采用5 mg/kg LPS气管注射构建小鼠ALI模型,2 h后尾静脉注射不同剂量ApoVs(10、20、40 μg/只),24 h后收集样本,通过苏木精-伊红染色法观察肺组织病理变化,RT-qPCR检测肺组织炎症因子及诱导型一氧化氮合酶(iNOS)、环氧化酶2(COX-2),酶联免疫吸附试验(ELISA)检测肺泡灌洗液(BALF)和血清炎症因子水平。
    结果 细胞实验显示,106、107 particles/ml ApoVs可降低MH-S细胞中IL-1β、IL-6、TNF-α的表达(P < 0.05),108 particles/ml组未见明显改善。动物实验显示,10 μg/只和20 μg/只ApoVs治疗组肺组织病理评分降低(P < 0.05),肺组织、BALF及血清中IL-1β、IL-6、TNF-α及iNOS、COX-2表达均下降(P < 0.05),而40 μg/只组未见明显改善。
    结论 hUCMSCs来源的ApoVs在细胞与动物水平均能有效缓解LPS诱导的感染性ALI,治疗效果并非随剂量升高而增强,存在最佳浓度窗口。

     

    Abstract:
    OBJECTIVE To explore the therapeutic effects of apoptotic vesicles (ApoVs) derived from human umbilical cord mesenchymal stem cells (hUCMSCs) on lipopolysaccharide (LPS)-induced injury in mouse alveolar macrophages (MH-S) and acute lung injury (ALI).
    METHODS In cell experiments, MH-S cells were induced to injury with 100 ng/ml LPS and treated with different concentrations of ApoVs (104~108 particles/ml) for 24 hours. Real-time quantitative reverse transcription polymerase chain reaction (RT-qPCR) was used to detect the expression of inflammatory cytokines interleukin (IL)-1β, IL-6 and tumor necrosis factor-α (TNF-α). In animal experiments, a mouse ALI model was established by intratracheal injection of 5 mg/kg LPS. Two hours later, different doses of ApoVs (10, 20, 40 μg/mouse) were injected intravenously through the tail vein. Samples were collected after 24 hours, and the pathological changes in lung tissues were observed through hematoxylin-eosin staining. RT-qPCR was used to detect inflammatory cytokines, inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) in lung tissues. Enzyme-linked immunosorbent assay (ELISA) was employed to detect the levels of inflammatory cytokines in bronchoalveolar lavage fluid (BALF) and serum.
    RESULTS Cell experiments showed that ApoVs at concentrations of 106and 107 particles/ml reduced the expression of IL-1β, IL-6 and TNF-α in MH-S cells (P < 0.05), while no significant improvement was observed in the 108 particles/ml group. Animal experiments revealed that the pathological scores of lung tissues in the group treated with ApoVs at doses of 10 μg/mouse and 20 μg/mouse significantly reduced (P < 0.05), as well as the expression of IL-1β, IL-6, TNF-α, iNOS and COX-2 in lung tissue, BALF and serum (P < 0.05), whereas no significant improvement was observed in the 40 μg/mouse group.
    CONCLUSIONS ApoVs derived from hUCMSCs can effectively alleviate LPS-induced infectious ALI at both the cellular and animal levels. The therapeutic effect does not increase with increasing dose, indicating the existence of an optimal concentration window.

     

/

返回文章
返回